Pages that link to "Q89299975"
Jump to navigation
Jump to search
The following pages link to Danilo Di Bona (Q89299975):
Displaying 14 items.
- Oxidative stress inhibits IFN-alpha-induced antiviral gene expression by blocking the JAK-STAT pathway. (Q40295951) (← links)
- KIR2DL3 and the KIR ligand groups HLA-A-Bw4 and HLA-C2 predict the outcome of hepatitis B virus infection. (Q40328386) (← links)
- Hyperthermia enhances CD95-ligand gene expression in T lymphocytes (Q40518664) (← links)
- The Cyclopentenone-Type Prostaglandin 15-Deoxy-Δ12,14-Prostaglandin J2 Inhibits CD95 Ligand Gene Expression in T Lymphocytes: Interference with Promoter Activation Via Peroxisome Proliferator-Activated Receptor-γ-Independent Mechanisms (Q40653210) (← links)
- Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. (Q42997332) (← links)
- Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes (Q43860724) (← links)
- Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study. (Q47366448) (← links)
- Treatment of hepatocellular carcinoma in compensated cirrhosis with radio-frequency thermal ablation (RFTA): a prospective study (Q58803387) (← links)
- Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing (Q64272869) (← links)
- Cost-effectiveness of grass pollen allergen immunotherapy in adults (Q89872228) (← links)
- Efficacy and safety of allergen immunotherapy in patients with allergy to molds: A systematic review (Q90767539) (← links)
- Safety and treatment compliance of subcutaneous immunotherapy: A 30-year retrospective study (Q91511927) (← links)
- The POU-Domain Transcription Factor Oct-6/POU3F1 as a Regulator of Cellular Response to Genotoxic Stress (Q92853714) (← links)
- Planned omalizumab discontinuation in csu management as a sustainable strategy: a 2-year real-life study (Q94458033) (← links)